Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block vs Deep Iliacus Plane Block for Analgesia in Intertrochanteric Femur Fractures
NCT07513740Recruiting
- Sponsor
- Erzincan Binali Yıldırım University
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms), sponsored by Erzincan Binali Yıldırım University. Primary endpoint: Pain during positioning for spinal anesthesia at 30 months. Started Mar 2026; status: recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07513740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07513740.